Healthcare >> CEO Interviews >> September 14, 2001
DANIEL L. KISNER, MD, President and CEO, joined Caliper Technologies
Corp. from Isis Pharmaceuticals where he was President and Chief
Operating Officer. He had previously been responsible for business
development, product development, and manufacturing as Executive Vice
President. Prior to joining Isis, Dr. Kisner was Division Vice President
of Pharmaceutical Development for Abbott Laboratories where he led a
team of 650 scientists, physicians and support personnel. His
responsibilities included the preclinical and clinical development of
all Abbott Laboratories' ethical pharmaceuticals. Dr. Kisner has also
held the position of Vice President of Clinical Research and Development
for International Studies for SmithKline Beckman Corporation and has a
tenured position in the Division of Oncology at The University of Texas,
San Antonio School of Medicine. Dr. Kisner is certified by the American
Board of Internal Medicine and certified in Medical Oncology. He is the
author of more than 50 scientific papers and 40 abstracts in clinical
journals and textbooks. Dr. Kisner received his MD from Georgetown
University in 1972. Profile
Technologies Corporation?
Dr. Kisner: Caliper was founded in 1995 to exploit the potential of
microfluidics ' the business
